Fmoc-alpha-Prg-D-Ala-OH

Fmoc-alpha-Prg-D-Ala-OH is an Fmoc-protected, chiral amino acid derivative built on a D-alanine stereocenter and bearing an N-terminal fluorenylmethoxycarbonyl (Fmoc) protecting group for orthogonal peptide synthesis. The side chain is represented by the D-Ala backbone, while the Prg residue indicates a protected arginine-like functionality (commonly used to control strongly basic guanidinium chemistry) that can be selectively unmasked under peptide-deprotection conditions. The molecule contains a free carboxylic acid for C-terminal coupling, along with protected amide/guanidinium motifs that modulate nucleophilicity and salt formation during synthesis. The combination of Fmoc strategy, defined D-configuration, and side-chain protection makes it a robust chiral intermediate for constructing peptides and peptidomimetic scaffolds with controlled basic-group behavior.

1. Peptide Synthesis

Fmoc-alpha-Prg-D-Ala-OH supports solid-phase peptide synthesis and related coupling workflows through its Fmoc-protected N-terminus and free carboxylic acid at the C-terminus. The D-alanine stereochemistry provides stereochemical control at the residue level, enabling incorporation of D-amino acid motifs that can influence backbone conformation and protease resistance in peptide analogs. The Prg-protected basic side-chain functionality is engineered to remain compatible with peptide coupling conditions while enabling later deprotection or functional exposure for salt-state tuning. Downstream peptide assembly can proceed to generate protected peptide fragments, sequence-defined D-Ala-containing peptides, and stereochemically characterized building blocks for library synthesis. The compound thus functions as a chiral peptide building block for amino acid sequence construction and protected side-chain management.

2. Peptidomimetics And SAR Studies

Fmoc-alpha-Prg-D-Ala-OH is suitable for peptidomimetic construction where D-alanine incorporation and controlled basic side-chain display are used to probe structure-activity relationships. The Fmoc group enables stepwise assembly into longer scaffolds, while the D-configuration can be leveraged to modulate hydrogen-bonding patterns, turn propensity, and conformational bias in analog series. The Prg-derived protected guanidinium-like functionality can be unmasked or transformed after assembly to study how cationic interactions contribute to binding and molecular recognition. The resulting D-Ala-containing peptide analogs can be used as chemical probes, SAR comparison reagents, and scaffold variants for medicinal chemistry and chemical biology screening campaigns. The amino acid derivative framework aligns with systematic amino acid derivatization strategies used to map stereochemical and side-chain effects.

3. Chemical Biology Labeling

Fmoc-alpha-Prg-D-Ala-OH can be applied in chemical biology workflows that require sequence-defined incorporation of D-amino acid residues into functional peptides for labeling and biophysical studies. The protected basic side-chain motif helps maintain charge control during synthesis, which can be important for reproducible conjugation behavior and for maintaining solubility during downstream modifications. The free carboxylic acid and Fmoc chemistry support coupling into peptide constructs that later undergo site-selective transformations, such as conjugation to probes, tags, or affinity handles after appropriate deprotection. D-alanine residues introduced via this building block can also serve as stereochemical controls to distinguish backbone-dependent interactions from side-chain-driven effects. The compound therefore supports the preparation of chemically defined peptide reagents used in biomolecular interaction mapping and mechanistic studies.

4. Protected Amino Acid Chemistry

Fmoc-alpha-Prg-D-Ala-OH functions as a protected amino acid intermediate designed for orthogonal handling of N-protection and side-chain basic-group protection during synthesis. The Fmoc group provides a removable N-terminal protecting strategy that can be compatible with standard peptide manufacturing sequences, while the Prg-protected guanidinium-like functionality is structured to resist premature side reactions under coupling conditions. The presence of a free carboxylic acid enables activation and coupling to carboxyl-reactive partners while maintaining the stereochemical integrity of the D-alanine center. The engineered protection pattern supports controlled deprotection timing, enabling sequential exposure of functional groups for subsequent derivatization, salt formation, or conjugation chemistry. This protected amino acid design aligns with process-relevant intermediate preparation where predictable functional group behavior is required for downstream peptide and peptidomimetic synthesis.

5. Pharmaceutical Intermediate Preparation

Fmoc-alpha-Prg-D-Ala-OH is applicable to pharmaceutical intermediate preparation for manufacturing of peptide-based research materials and processable peptidomimetic intermediates. The Fmoc-protected architecture and defined residue stereochemistry facilitate reproducible incorporation into longer sequences used as reference standards, process intermediates, or analytical comparators in peptide chemistry programs. The Prg-protected basic side chain supports controlled handling of strongly cationic functionality, which can otherwise complicate solubility, purification, and reproducibility during scale-up. The free carboxylic acid enables conversion into activated coupling forms or direct peptide coupling steps within controlled manufacturing workflows. The compound thereby serves as a chiral, protection-managed building block that can be integrated into industrial fine chemical synthesis routes for peptide-derived materials.

6. Analytical Research Standards

Fmoc-alpha-Prg-D-Ala-OH can be employed in analytical research to generate defined D-Ala-containing peptide standards and method-development materials for LC-MS, HPLC, and peptide mapping workflows. The Fmoc and Prg-protected functionalities provide a chemically well-defined starting point for synthesizing reference peptides with predictable charge states and fragmentation behavior. D-alanine stereochemistry can be used to create stereospecific standards that help differentiate epimeric or isomeric peptide products during synthesis monitoring and impurity profiling. The protected side-chain motif supports consistent derivatization and deprotection sequences, enabling reproducible preparation of analytical calibrants and retention-time references. The compound therefore supports rigorous analytical characterization of peptide synthesis outcomes and stereochemical integrity in applied amino acid chemistry.

1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

2. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

3. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

4. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

5. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active